People: Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

189.97USD
19 Dec 2014
Price Change (% chg)

$2.68 (+1.43%)
Prev Close
$187.29
Open
$187.80
Day's High
$190.40
Day's Low
$184.67
Volume
1,471,849
Avg. Vol
1,191,687
52-wk High
$197.37
52-wk Low
$102.30

Search Stocks

Whitfield, Roy 

Brief Biography

Mr. Roy A. Whitfield is an Independent Director of Illumina, Inc., since January 2007. Mr. Whitfield is the former Chairman of the Board and Chief Executive Officer of Incyte Corporation (formerly Incyte Genomics), a NASDAQ-listed drug discovery and development company he co-founded in 1991. From 1993 to 2001, Mr. Whitfield served as its Chief Executive Officer and, from November 2001 until his retirement in June 2003, as its Chairman. Mr. Whitfield remains on the board of Incyte Corporation. From 1984 to 1989, Mr. Whitfield held senior operating and business development positions with Technicon Instruments Corporation, a medical instrumentation company, and its predecessor company, Cooper Biomedical, Inc., a biotechnology and medical diagnostics company. Earlier, Mr. Whitfield spent seven years with the Boston Consulting Group’s international consulting practice. In addition to serving on the Incyte Board, since 2000 he has served as a director of Nektar Therapeutics, a NASDAQ-listed clinical-stage biopharmaceutical company, and he also serves as a director of Station X Inc., a privately-held developer of software products for analyzing largescale human genome information. Mr. Whitfield also served as a past director of Solexa, Inc. from 2006 until its sale to Illumina in 2007. Mr. Whitfield received a B.S. in Mathematics from Oxford University and an M.B.A. from Stanford University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

William Rastetter

--

Francis deSouza

6,727,490

Jay Flatley

7,296,270

Marc Stapley

2,220,800

David Walt

--

Mostafa Ronaghi

2,079,570
As Of 28 Dec 2013
Search Stocks